Development and screening of a series of antibody-conjugated and silica-coated iron oxide nanoparticles for targeting the prostate-specific membrane antigen.
about
(2S)-2-(3-(1-Carboxy-5-(4-211At-Astatobenzamido)Pentyl)Ureido)-Pentanedioic Acid for PSMA-Targeted α-Particle Radiopharmaceutical Therapy.Development and Application of a Novel Model System to Study "Active" and "Passive" Tumor Targeting.Boronic acid recognition based-gold nanoparticle-labeling strategy for the assay of sialic acid expression on cancer cell surface by inductively coupled plasma mass spectrometry.
P2860
Development and screening of a series of antibody-conjugated and silica-coated iron oxide nanoparticles for targeting the prostate-specific membrane antigen.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Development and screening of a ...... ate-specific membrane antigen.
@en
Development and screening of a ...... ate-specific membrane antigen.
@nl
type
label
Development and screening of a ...... ate-specific membrane antigen.
@en
Development and screening of a ...... ate-specific membrane antigen.
@nl
prefLabel
Development and screening of a ...... ate-specific membrane antigen.
@en
Development and screening of a ...... ate-specific membrane antigen.
@nl
P2093
P2860
P356
P1433
P1476
Development and screening of a ...... ate-specific membrane antigen.
@en
P2093
Amarnath Mukherjee
Charles Holz
Prakash Kulkarni
Richard Baldwin
Robert H Getzenberg
Sage Olson
Shawn E Lupold
Theodore L DeWeese
Thomas Darlington
P2860
P304
P356
10.1002/CMDC.201300549
P50
P577
2014-03-03T00:00:00Z